Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Although technology-assisted diabetes prevention programs (DPPs) have been shown to improve glycemic control and weight loss, information are limited regarding relevant costs and their cost-effectiveness. To describe a retrospective within-trial cost and cost-effectiveness analysis (CEA) to compare a digital-based DPP (d-DPP) with small group education (SGE), over a 1-year study period. The costs were summarized into direct medical costs, direct nonmedical costs (i.e., times that participants spent engaging with the interventions), and indirect costs (i.e., lost work productivity costs). The CEA was measured by the incremental cost-effectiveness ratio (ICER). Sensitivity analysis was performed using nonparametric bootstrap analysis. Over 1 year, the direct medical costs, direct nonmedical costs, and indirect costs per participant were $4,556, $1,595, and $6,942 in the d-DPP group versus $4,177, $1,350, and $9,204 in the SGE group. The CEA results showed cost savings from d-DPP relative to SGE based on a societal perspective. Using a private payer perspective for d-DPP, ICERs were $4,739 and $114 to obtain an additional unit reduction in HbA1c (%) and weight (kg), and were $19,955 for an additional unit gain of quality-adjusted life years (QALYs) compared to SGE, respectively. From a societal perspective, bootstrapping results indicated that d-DPP has a 39% and a 69% probability, at a willingness-to-pay of $50,000/QALY and $100,000/QALY, respectively, of being cost-effective. The d-DPP was cost-effective and offers the prospect of high scalability and sustainability due to its program features and delivery modes, which can be easily translated to other settings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Organization for Economic Co-operation and Development
Moise, E. (1988) · World Competition Law and Economics Review · doi:10.1016/0048-9697(80)90073-x · Cited by 1,564
Cost-Effectiveness in Health and Medicine
(2016) · doi:10.1093/acprof:oso/9780190492939.001.0001 · Cited by 1,552
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
The Godin-Shephard Leisure-Time Physical Activity Questionnaire
Godin, G. (2011) · Health & fitness journal of Canada · doi:10.14288/hfjc.v4i1.82 · Cited by 922
Economic Evaluation in Clinical Trials
Glick, H. A., Doshi, J. A., Sonnad, S. S., & Polsky, D. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199685028.001.0001 · Cited by 910
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Organization for Economic Cooperation and Development
(2021) · Permanent Missions to the United Nations · doi:10.18356/9789210056755c215 · Cited by 725
Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Kessler, R. C., Ames, M., Hymel, P. A., Loeppke, R., McKenas, D. K., Richling, D. E., Stang, P. E., & Ustun, T. B. (2004) · Journal of Occupational & Environmental Medicine · doi:10.1097/01.jom.0000126683.75201.c5 · Cited by 447
Briggs, A. H., O'Brien, B. J., & Blackhouse, G. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140534 · Cited by 404
Maintenance after Pulmonary Rehabilitation in Chronic Lung Disease: A Randomized Trial
Ries, A. L., Kaplan, R. M., Myers, R., & Prewitt, L. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-318oc · Cited by 371
The Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.36 · Cited by 358
Translating the Diabetes Prevention Program
Kramer, M. K., Kriska, A. M., Venditti, E. M., Miller, R. G., Brooks, M. M., Burke, L. E., Siminerio, L. M., Solano, F. X., & Orchard, T. J. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.07.020 · Cited by 336
Efficacy of Commercial Weight-Loss Programs: An Updated Systematic Review
Gudzune, K. A., Doshi, R. S., Mehta, A. K., Chaudhry, Z. W., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., & Clark, J. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2238 · Cited by 325
Preventing Type 2 Diabetes in Communities Across the U.S.
Albright, A. L., & Gregg, E. W. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.009 · Cited by 297
Diabetes Prevention Program Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2518 · Cited by 262
How to Estimate Productivity Costs in Economic Evaluations
Krol, M., & Brouwer, W. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0132-3 · Cited by 233
A Novel Diabetes Prevention Intervention Using a Mobile App
Fukuoka, Y., Gay, C. L., Joiner, K. L., & Vittinghoff, E. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.01.003 · Cited by 204
Kaplan, R. M., Sieber, W. J., & Ganiats, T. G. (1997) · Psychology & Health · doi:10.1080/08870449708406739 · Cited by 195
Sun, Y., You, W., Almeida, F., Estabrooks, P., & Davy, B. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.11.016 · Cited by 186
Self-citationZhou, X., Siegel, K. R., Ng, B. P., Jawanda, S., Proia, K. K., Zhang, X., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0018 · Cited by 173
Bhopal, R. S., Douglas, A., Wallia, S., Forbes, J. F., Lean, M. E. J., Gill, J. M. R., McKnight, J. A., Sattar, N., Sheikh, A., Wild, S. H., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70204-3 · Cited by 149
Meta‐ and cost‐effectiveness analysis of commercial weight loss strategies
Finkelstein, E. A., & Kruger, E. (2014) · Obesity · doi:10.1002/oby.20824 · Cited by 147
Sepah, S. C., Jiang, L., & Peters, A. L. (2014) · The Diabetes Educator · doi:10.1177/0145721714531339 · Cited by 139
Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk
Jacobs-van der Bruggen, M. A. M., Bos, G., Bemelmans, W. J., Hoogenveen, R. T., Vijgen, S. M., & Baan, C. A. (2007) · Diabetes Care · doi:10.2337/dc06-0690 · Cited by 137
Overview of Cost-effectiveness Analysis
Sanders, G. D., Maciejewski, M. L., & Basu, A. (2019) · JAMA · doi:10.1001/jama.2019.1265 · Cited by 130
Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update
Sepah, S. C., Jiang, L., Ellis, R. J., McDermott, K., & Peters, A. L. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000422 · Cited by 122
Roberts, S., Barry, E., Craig, D., Airoldi, M., Bevan, G., & Greenhalgh, T. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017184 · Cited by 122
Toro-Ramos, T., Michaelides, A., Anton, M., Karim, Z., Kang-Oh, L., Argyrou, C., Loukaidou, E., Charitou, M. M., Sze, W., & Miller, J. D. (2020) · JMIR mHealth and uHealth · doi:10.2196/17842 · Cited by 107
Lindgren, P., Lindström, J., Tuomilehto, J., Uusitupa, M., Peltonen, M., Jönsson, B., de Faire, U., Hellénius, M.-L., & The DPS Study Group (2007) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462307070286 · Cited by 97
A Review of Technology-Assisted Interventions for Diabetes Prevention
Grock, S., Ku, J.-H., Kim, J., & Moin, T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0948-2 · Cited by 91
Effects of a Digital Diabetes Prevention Program: An RCT
Katula, J. A., Dressler, E. V., Kittel, C. A., Harvin, L. N., Almeida, F. A., Wilson, K. E., Michaud, T. L., Porter, G. C., Brito, F. A., Goessl, C. L., et al. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.10.023 · Cited by 86
Self-citationLog Often, Lose More: Electronic Dietary Self‐Monitoring for Weight Loss
Harvey, J., Krukowski, R., Priest, J., & West, D. (2019) · Obesity · doi:10.1002/oby.22382 · Cited by 78
Cost of a Group Translation of the Diabetes Prevention Program
Lawlor, M. S., Blackwell, C. S., Isom, S. P., Katula, J. A., Vitolins, M. Z., Morgan, T. M., & Goff, D. C. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.016 · Cited by 55
Self-citationPalmer, A. J., & Tucker, D. M. D. (2012) · Primary Care Diabetes · doi:10.1016/j.pcd.2011.10.006 · Cited by 53
Breeze, P. R., Thomas, C., Squires, H., Brennan, A., Greaves, C., Diggle, P. J., Brunner, E., Tabak, A., Preston, L., & Chilcott, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13314 · Cited by 50
Neumann, A., Lindholm, L., Norberg, M., Schoffer, O., Klug, S. J., & Norström, F. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-016-0851-9 · Cited by 42
Uribe, J. M., Pinto, D. M., Vecino-Ortiz, A. I., Gómez–Restrepo, C., & Rondón, M. (2017) · Value in Health Regional Issues · doi:10.1016/j.vhri.2017.03.001 · Cited by 42
Almeida, F. A., Michaud, T. L., Wilson, K. E., Schwab, R. J., Goessl, C., Porter, G. C., Brito, F. A., Evans, G., Dressler, E. V., Boggs, A. E., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.105877 · Cited by 38
Self-citationHuang, S. J., Galárraga, O., Smith, K. A., Fuimaono, S. D., & McGarvey, S. T. (2019) · Human Resources for Health · doi:10.1186/s12960-019-0356-6 · Cited by 34
Krukowski, R. A., Pope, R. A., Love, S., Lensing, S., Felix, H. C., Prewitt, T. E., & West, D. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.027 · Cited by 30
A Cost and Cost-Benefit Analysis of the Stand More AT Work (SMArT Work) Intervention
Munir, F., Miller, P., Biddle, S., Davies, M. J., Dunstan, D. W., Esliger, D., Gray, L. J., O'Connell, S. E., Waheed, G., Yates, T. E., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041214 · Cited by 30
Smith, K. J., Kuo, S., Zgibor, J. C., McTigue, K. M., Hess, R., Bhargava, T. D., & Bryce, C. L. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.02.036 · Cited by 29
Egede, L. E., Strom, J. L., Fernandes, J., Knapp, R. G., & Rojugbokan, A. (2011) · Trials · doi:10.1186/1745-6215-12-231 · Cited by 24
Duijzer, G., Bukman, A. J., Meints-Groenveld, A., Haveman‐Nies, A., Jansen, S. C., Heinrich, J., Hiddink, G. J., Feskens, E. J. M., & de Wit, G. A. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4529-8 · Cited by 19
Ben, Â. J., Jelsma, J. G. M., Renaud, L. R., Huysmans, M. A., van Nassau, F., van der Beek, A. J., van der Ploeg, H. P., van Dongen, J. M., & Bosmans, J. E. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001930 · Cited by 18
Wilson, K. E., Michaud, T. L., Almeida, F. A., Schwab, R. J., Porter, G. C., Aquilina, K. H., Brito, F. A., Golden, C. A., Dressler, E. V. M., Kittel, C., et al. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab010 · Cited by 17
Self-citationMichaud, T. L., You, W., Estabrooks, P. A., Leonard, K. S., Rydell, S. A., Mullane, S. L., Pereira, M. A., & Buman, M. P. (2022) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.4022 · Cited by 15
Self-citationMichaud, T. L., Wilson, K. E., Silva, F., Almeida, F. A., Katula, J. A., & Estabrooks, P. A. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab054 · Cited by 10
Self-citation
Research works printed but not linked: 2
- International Diabetes Federation, 2021
- Centers for Disease Control and Prevention, 2020, National diabetes statistics report, 2020, 12
Cited by
Abusamaan, M. S., Ballreich, J., Dobs, A., Kane, B., Maruthur, N., McGready, J., Riekert, K., Wanigatunga, A. A., Alderfer, M., Alver, D., et al. (2024) · Trials · doi:10.1186/s13063-024-08177-8 · Cited by 16
Park, S., Ballreich, J. M., Ward, T., & Shi, L. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15807 · Cited by 10
“1,15,16 However, previous studies did not consider adherence to the programme, although it plays a vital role in the effect of in-person and digital DPPs. 17 d-DPP”
Teoh, K. W., Baek, Y., Ademi, Z., & Lee, S. W. H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16350 · Cited by 9
Aslam, A., Butt, M. D., Javaid, I., Malik, T., Gull, Z., Mahmood, A., Afzal, A., Adnan, A., & Ong, S. C. (2025) · BMC Public Health · doi:10.1186/s12889-025-25319-y · Cited by 8
“Additionally, assessing the cost-effectiveness of different intervention strategies will help ensure that resources are utilized efficiently [53].”
Using Digital Health Technology to Prevent and Treat Diabetes
Clements, M. A., Kaufman, N., & Mel, E. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2506 · Cited by 1
Metadata
- Authors
- Michaud, T. L., Wilson, K. E., Katula, J. A., You, W., & Estabrooks, P. A.
- Affiliations
- University of Nebraska Medical Center (US)
- Georgia State University (US)
- Wake Forest University (US)
- University of Virginia (US)
- University of Utah (US)
- Corresponding author
- Michaud, Tzeyu L
- Venue
- Translational Behavioral Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-02-21
- Volume
- 13
- Issue
- 7
- Pages
- 501-510
- ISSN
- 1613-9860 (ISSN-L)
- 1869-6716
- OpenAlex
- W4321437515
- Cited by
- 12
- References
- 52
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Translational Behavioral Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Omada Health
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- Diabetes Prevention Program, digital health interventions, cost-effectiveness, small group instruction, HbA1c reduction, weight loss, quality-adjusted life years, incremental cost-effectiveness ratio, type 2 diabetes prevention
- MeSH terms
- Cost-Effectiveness Analysis, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Humans, Retrospective Studies, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.